103 related articles for article (PubMed ID: 22052860)
1. Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome.
Coccia P; Mastrangelo S; Ruggiero A; Scalzone M; Rosolen A; Maurizi P; Riccardi R
Pediatr Blood Cancer; 2012 Aug; 59(2):318-9. PubMed ID: 22052860
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of children with non-hodgkin lymphoma associated with primary immune deficiency diseases: descriptions of five patients.
Emir S; Vezir E; Azkur D; Demir HA; Metin A
Pediatr Hematol Oncol; 2013 Sep; 30(6):544-53. PubMed ID: 23647505
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of non-Hodgkin's lymphoma using R-CHOP in a patient with Wiskott-Aldrich syndrome followed by a reduced-intensity stem cell transplant.
Koga Y; Takada H; Suminoe A; Ohga S; Hara T
Pediatr Transplant; 2014 Sep; 18(6):E208-11. PubMed ID: 24930759
[TBL] [Abstract][Full Text] [Related]
4. Burkitt lymphoma-induced ileocolic intussusception in Wiskott-Aldrich syndrome.
Pasic S; Vujic D; Djuricic S; Jevtic D; Grujic B
J Pediatr Hematol Oncol; 2006 Jan; 28(1):48-9. PubMed ID: 16394894
[TBL] [Abstract][Full Text] [Related]
5. Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma.
Tavil B; Erdem AY; Azik F; Isik P; Metin A; Emir S; Uckan D; Tunc B
Pediatr Transplant; 2013 Sep; 17(6):E146-8. PubMed ID: 23773507
[TBL] [Abstract][Full Text] [Related]
6. Sclerosing cholangitis and intracranial lymphoma in a child with classical Wiskott-Aldrich syndrome.
Vignesh P; Suri D; Rawat A; Lau YL; Bhatia A; Das A; Srinivasan A; Dhandapani S
Pediatr Blood Cancer; 2017 Jan; 64(1):106-109. PubMed ID: 27566838
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
8. Distinct apoptotic signaling characteristics of the anti-CD40 monoclonal antibody dacetuzumab and rituximab produce enhanced antitumor activity in non-Hodgkin lymphoma.
Lewis TS; McCormick RS; Emmerton K; Lau JT; Yu SF; McEarchern JA; Grewal IS; Law CL
Clin Cancer Res; 2011 Jul; 17(14):4672-81. PubMed ID: 21610152
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin's and non-Hodgkin's lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature.
Du S; Scuderi R; Malicki DM; Willert J; Bastian J; Weidner N
Pediatr Dev Pathol; 2011; 14(1):64-70. PubMed ID: 20429642
[TBL] [Abstract][Full Text] [Related]
10. Partial remission of psoriasis following rituximab therapy for non-Hodgkin lymphoma.
Singh F; Weinberg JM
Cutis; 2005 Sep; 76(3):186-8. PubMed ID: 16268262
[TBL] [Abstract][Full Text] [Related]
11. Relationship of immunodeficiency to lymphoid malignancy.
Kersey JH; Shapiro RS; Filipovich AH
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S10-2. PubMed ID: 2840629
[TBL] [Abstract][Full Text] [Related]
12. Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma.
Nagai H; Ogura M; Kusumoto S; Takahashi N; Yamaguchi M; Takayama N; Kinoshita T; Motoji T; Ohyashiki K; Kosugi H; Matsuda S; Ohnishi K; Omachi K; Hotta T
Eur J Haematol; 2011 Feb; 86(2):117-23. PubMed ID: 21070370
[TBL] [Abstract][Full Text] [Related]
13. An unusual self-limited clonal Mott cell proliferation with lymphoplasmacytic lymphoma-like features in a child with the Wiskott-Aldrich syndrome and Von Recklinghausen's neurofibromatosis.
Rampisela D; Donner LR
Pathol Res Pract; 2010 Jul; 206(7):467-71. PubMed ID: 19713050
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.
Tanaka T; Shimada K; Yamamoto K; Hirooka Y; Niwa Y; Sugiura I; Kitamura K; Kosugi H; Kinoshita T; Goto H; Nakamura S
Ann Hematol; 2012 Mar; 91(3):383-90. PubMed ID: 21822617
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival following non-Hodgkin's lymphoma arising in Wiskott-Aldrich syndrome.
Gilson D; Taylor RE
Clin Oncol (R Coll Radiol); 1999; 11(4):283-5. PubMed ID: 10473730
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-CD20 monoclonal antibody.
Ahmed S; Singh A; Krauss J; Wentz T; Gunaratnam NT
Am J Clin Oncol; 2003 Aug; 26(4):408-10. PubMed ID: 12902896
[TBL] [Abstract][Full Text] [Related]
17. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL
Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785
[TBL] [Abstract][Full Text] [Related]
18. Primary reticulum cell sarcoma of the brain in Wiskott-Aldrich syndrome. Report of a case.
Model LM
Arch Neurol; 1977 Oct; 34(10):633-5. PubMed ID: 334130
[TBL] [Abstract][Full Text] [Related]
19. [A case of non-Hodgkin lymphoma with complete remission achieved by carboplatin].
Nagai H; Wakita A; Murase T; Fujiwara Y; Nakaide Y; Tanaka M; Hirota Y
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2797-800. PubMed ID: 3046495
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS).
Dembowska-Baginska B; Perek D; Brozyna A; Wakulinska A; Olczak-Kowalczyk D; Gladkowska-Dura M; Grajkowska W; Chrzanowska KH
Pediatr Blood Cancer; 2009 Feb; 52(2):186-90. PubMed ID: 18937313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
